Your browser doesn't support javascript.
loading
Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis.
Meunier, P; Dequidt, L; Barnetche, T; Lazaro, E; Duffau, P; Richez, C; Couzi, L; Truchetet, M-E; Seneschal, J.
Afiliação
  • Meunier P; Department of Rheumatology, Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Dequidt L; Department of Dermatology and Paediatric Dermatology, National Reference Center for Rare Skin Diseases, Saint-André Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Barnetche T; Department of Rheumatology, Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Lazaro E; Immunology Laboratory, ImmunoConcept, UMR CNRS 5164, University Hospital of Bordeaux, Bordeaux, France.
  • Duffau P; Department of Internal Medicine, Haut-Lévêque, University Hospital of Bordeaux, Pessac, France.
  • Richez C; Immunology Laboratory, ImmunoConcept, UMR CNRS 5164, University Hospital of Bordeaux, Bordeaux, France.
  • Couzi L; Department of Internal Medicine, Saint-André Hospital, University of Bordeaux, Bordeaux, France.
  • Truchetet ME; Department of Rheumatology, Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Seneschal J; Immunology Laboratory, ImmunoConcept, UMR CNRS 5164, University Hospital of Bordeaux, Bordeaux, France.
J Eur Acad Dermatol Venereol ; 33(2): 405-409, 2019 Feb.
Article em En | MEDLINE | ID: mdl-29888406
ABSTRACT

BACKGROUND:

Survival can be threatened in certain forms of systemic sclerosis (SSc) so clear prognostic factors are needed.

OBJECTIVES:

The aim of this meta-analysis was to assess the association between the presence of digital ulcers (DUs) and mortality in SSc.

METHODS:

We performed a systematic review and meta-analysis in the Pubmed and Scopus databases from the earliest records to May 2017. Two research strategies were performed « systemic sclerosis ¼ and « digital ulcers ¼ (strategy A); « systemic sclerosis ¼ and « mortality ¼ (strategy B). The primary outcome was the mortality associated with the presence of DUs in patients with SSc.

RESULTS:

The literature search identified 1473 citations. Fifty-nine studies were examined for full text. Ten articles were included for the meta-analysis. SSc patients with DUs had an increased pooled mortality risk RR = 1.53 (IC 95% [1.23-1.90]).

CONCLUSIONS:

This meta-analysis revealed a higher mortality in SSc patients with associated DUs. Having DUs may be a predictive factor of developing organ involvement such as pulmonary or cardiovascular events that could be associated with poor survival. It suggests that early screening of DUs in SSc patients is important to identify patients most at risk of poor survival.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea / Causas de Morte Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea / Causas de Morte Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article